Scientech Research »

Intra Cellular Therapies shares owned by Scientech Research

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Scientech Research from 13F filings

Historical chart of Scientech Research investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Scientech Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Scientech Research

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.4M 35k 68.49

More positions owned by Scientech Research

Meta Platforms Cl A (META)
Microstrategy Cl A New (MSTR)
Duolingo Cl A Com (DUOL)
Ensign (ENSG)
Constellation Energy (CEG)
Visa Com Cl A (V)
Applovin Corp Com Cl A (APP)
Sherwin-Williams Company (SHW)
Rocket Lab Usa (RKLB)
Ulta Salon, Cosmetics & Fragrance (ULTA)
Intuit (INTU)
Netflix (NFLX)
Sun Communities (SUI)
Talen Energy Corp (TLN)
Arista Networks (ANET)

View all positions for Scientech Research

Top funds holding Intra Cellular Therapies

Vanguard Group
BlackRock
BlackRock
Jpmorgan Chase & Co
Daniel D. Thurber
Invesco
Bellevue Group
State Street Corporation
Franklin Resources
ClearBridge Advisors
Geode Capital Management
Perceptive Advisors
Pictet Asset Management Holding SA
Suvretta Capital Management
Deep Track Capital

View all funds holding Intra Cellular Therapies